nodes	percent_of_prediction	percent_of_DWPC	metapath
Amiloride—ASIC2—nerve—peripheral nervous system neoplasm	0.0368	0.197	CbGeAlD
Amiloride—ASIC2—ganglion—peripheral nervous system neoplasm	0.0364	0.194	CbGeAlD
Amiloride—ASIC1—ganglion—peripheral nervous system neoplasm	0.023	0.123	CbGeAlD
Amiloride—SLC9A1—Osteoclast Signaling—IFNB1—peripheral nervous system neoplasm	0.0151	0.064	CbGpPWpGaD
Amiloride—ASIC1—trigeminal ganglion—peripheral nervous system neoplasm	0.0113	0.0604	CbGeAlD
Amiloride—SCNN1G—parotid gland—peripheral nervous system neoplasm	0.0109	0.058	CbGeAlD
Amiloride—PLAU—trigeminal ganglion—peripheral nervous system neoplasm	0.0103	0.0548	CbGeAlD
Amiloride—PLAU—Complement and Coagulation Cascades—CD55—peripheral nervous system neoplasm	0.00945	0.0402	CbGpPWpGaD
Amiloride—SCNN1B—parotid gland—peripheral nervous system neoplasm	0.00918	0.049	CbGeAlD
Amiloride—PLAU—AP-1 transcription factor network—NTS—peripheral nervous system neoplasm	0.0086	0.0365	CbGpPWpGaD
Amiloride—SCNN1A—parotid gland—peripheral nervous system neoplasm	0.00848	0.0453	CbGeAlD
Amiloride—PLAU—Beta2 integrin cell surface interactions—KNG1—peripheral nervous system neoplasm	0.00782	0.0332	CbGpPWpGaD
Amiloride—ASIC2—cerebellum—peripheral nervous system neoplasm	0.0078	0.0416	CbGeAlD
Amiloride—PLAU—ATF-2 transcription factor network—NF1—peripheral nervous system neoplasm	0.00716	0.0304	CbGpPWpGaD
Amiloride—SLC22A1—ganglion—peripheral nervous system neoplasm	0.00698	0.0373	CbGeAlD
Amiloride—SLC22A2—Abacavir transmembrane transport—ABCB1—peripheral nervous system neoplasm	0.00657	0.0279	CbGpPWpGaD
Amiloride—PLAU—FGF signaling pathway—NCAM1—peripheral nervous system neoplasm	0.00654	0.0278	CbGpPWpGaD
Amiloride—SLC9A1—Defective B3GAT3 causes JDSSDHD—GNS—peripheral nervous system neoplasm	0.00624	0.0265	CbGpPWpGaD
Amiloride—SLC22A1—Abacavir transmembrane transport—ABCB1—peripheral nervous system neoplasm	0.00612	0.026	CbGpPWpGaD
Amiloride—SLC22A2—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—peripheral nervous system neoplasm	0.00599	0.0255	CbGpPWpGaD
Amiloride—SLC22A1—Neurotransmitter Clearance In The Synaptic Cleft—BCHE—peripheral nervous system neoplasm	0.00558	0.0237	CbGpPWpGaD
Amiloride—SCNN1G—cerebellum—peripheral nervous system neoplasm	0.00502	0.0268	CbGeAlD
Amiloride—SCNN1D—cerebellum—peripheral nervous system neoplasm	0.00502	0.0268	CbGeAlD
Amiloride—ASIC1—cerebellum—peripheral nervous system neoplasm	0.00493	0.0263	CbGeAlD
Amiloride—SLC22A2—trigeminal ganglion—peripheral nervous system neoplasm	0.00486	0.0259	CbGeAlD
Amiloride—PLAU—Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling—HGF—peripheral nervous system neoplasm	0.00484	0.0206	CbGpPWpGaD
Amiloride—PLAU—ATF-2 transcription factor network—TH—peripheral nervous system neoplasm	0.00475	0.0202	CbGpPWpGaD
Amiloride—SLC9A1—cerebellum—peripheral nervous system neoplasm	0.00472	0.0252	CbGeAlD
Amiloride—PLAU—Complement and Coagulation Cascades—KNG1—peripheral nervous system neoplasm	0.00443	0.0188	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—TH—peripheral nervous system neoplasm	0.00414	0.0176	CbGpPWpGaD
Amiloride—PLAU—FGF signaling pathway—HGF—peripheral nervous system neoplasm	0.00396	0.0168	CbGpPWpGaD
Amiloride—SLC22A2—Abacavir transport and metabolism—ABCB1—peripheral nervous system neoplasm	0.00377	0.016	CbGpPWpGaD
Amiloride—SLC22A1—Abacavir transport and metabolism—ABCB1—peripheral nervous system neoplasm	0.00352	0.0149	CbGpPWpGaD
Amiloride—SLC9A1—Carbohydrate metabolism—GNS—peripheral nervous system neoplasm	0.00335	0.0142	CbGpPWpGaD
Amiloride—PLAU—Validated transcriptional targets of AP1 family members Fra1 and Fra2—CDKN2A—peripheral nervous system neoplasm	0.00323	0.0137	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00313	0.0133	CbGpPWpGaD
Amiloride—PLAU—FGF signaling pathway—MET—peripheral nervous system neoplasm	0.00312	0.0133	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—IFNB1—peripheral nervous system neoplasm	0.00301	0.0128	CbGpPWpGaD
Amiloride—SLC9A1—G Protein Signaling Pathways—GNAS—peripheral nervous system neoplasm	0.00298	0.0127	CbGpPWpGaD
Amiloride—PLAU—FGF signaling pathway—PTPN11—peripheral nervous system neoplasm	0.00289	0.0123	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00237	0.0101	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00237	0.0101	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00237	0.0101	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00237	0.0101	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00237	0.0101	CbGpPWpGaD
Amiloride—SLC9A1—Signaling mediated by p38-alpha and p38-beta—TP53—peripheral nervous system neoplasm	0.00208	0.00886	CbGpPWpGaD
Amiloride—SLC9A1—Carbohydrate metabolism—ENO2—peripheral nervous system neoplasm	0.00203	0.00862	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.00194	0.00825	CbGpPWpGaD
Amiloride—PLAU—E2F transcription factor network—CDKN2A—peripheral nervous system neoplasm	0.00188	0.00798	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.00166	0.00704	CbGpPWpGaD
Amiloride—SLC9A1—Carbohydrate metabolism—SLC2A1—peripheral nervous system neoplasm	0.00163	0.00695	CbGpPWpGaD
Amiloride—SLC9A1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.00163	0.00693	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.00163	0.00691	CbGpPWpGaD
Amiloride—SLC22A4—cerebellum—peripheral nervous system neoplasm	0.00157	0.00839	CbGeAlD
Amiloride—SLC9A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.00156	0.00665	CbGpPWpGaD
Amiloride—PLAU—Senescence and Autophagy in Cancer—CDKN2A—peripheral nervous system neoplasm	0.0014	0.00596	CbGpPWpGaD
Amiloride—PLAU—Wnt Signaling Pathway—MYC—peripheral nervous system neoplasm	0.00136	0.00579	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—CDKN2A—peripheral nervous system neoplasm	0.00136	0.00579	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.00133	0.00567	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—MYC—peripheral nervous system neoplasm	0.00132	0.00559	CbGpPWpGaD
Amiloride—ASIC2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.00131	0.00556	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—ERBB2—peripheral nervous system neoplasm	0.0013	0.00553	CbGpPWpGaD
Amiloride—PLAU—E2F transcription factor network—MYC—peripheral nervous system neoplasm	0.00127	0.0054	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.00126	0.00534	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.00126	0.00534	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.00126	0.00534	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.00126	0.00534	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.00126	0.00534	CbGpPWpGaD
Amiloride—SLC9A1—G Protein Signaling Pathways—NRAS—peripheral nervous system neoplasm	0.00125	0.0053	CbGpPWpGaD
Amiloride—SLC9A1—Endothelins—HRAS—peripheral nervous system neoplasm	0.00125	0.00529	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—NRAS—peripheral nervous system neoplasm	0.00113	0.00481	CbGpPWpGaD
Amiloride—PLAU—FGF signaling pathway—AKT1—peripheral nervous system neoplasm	0.00112	0.00477	CbGpPWpGaD
Amiloride—SLC9A1—Endothelins—AKT1—peripheral nervous system neoplasm	0.0011	0.00468	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.0011	0.00467	CbGpPWpGaD
Amiloride—PLAU—AP-1 transcription factor network—TP53—peripheral nervous system neoplasm	0.00108	0.00459	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.00101	0.0043	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.00101	0.0043	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.00101	0.0043	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.00101	0.0043	CbGpPWpGaD
Amiloride—SCNN1D—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.00101	0.0043	CbGpPWpGaD
Amiloride—Chest pain—Alitretinoin—peripheral nervous system neoplasm	0.000997	0.00173	CcSEcCtD
Amiloride—Arthralgia—Alitretinoin—peripheral nervous system neoplasm	0.000997	0.00173	CcSEcCtD
Amiloride—Abdominal pain—Isotretinoin—peripheral nervous system neoplasm	0.000997	0.00173	CcSEcCtD
Amiloride—Abdominal pain—Tretinoin—peripheral nervous system neoplasm	0.000997	0.00173	CcSEcCtD
Amiloride—SCNN1D—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000992	0.00421	CbGpPWpGaD
Amiloride—SCNN1B—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000992	0.00421	CbGpPWpGaD
Amiloride—SCNN1A—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000992	0.00421	CbGpPWpGaD
Amiloride—ASIC1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000992	0.00421	CbGpPWpGaD
Amiloride—SCNN1G—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000992	0.00421	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—NRAS—peripheral nervous system neoplasm	0.000991	0.00421	CbGpPWpGaD
Amiloride—Coma—Doxorubicin—peripheral nervous system neoplasm	0.000991	0.00172	CcSEcCtD
Amiloride—Flatulence—Cisplatin—peripheral nervous system neoplasm	0.000983	0.0017	CcSEcCtD
Amiloride—Anorexia—Dactinomycin—peripheral nervous system neoplasm	0.000982	0.0017	CcSEcCtD
Amiloride—PLAU—Endochondral Ossification—AKT1—peripheral nervous system neoplasm	0.00098	0.00416	CbGpPWpGaD
Amiloride—Hepatic function abnormal—Epirubicin—peripheral nervous system neoplasm	0.000973	0.00169	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—MYC—peripheral nervous system neoplasm	0.000973	0.00414	CbGpPWpGaD
Amiloride—Confusional state—Alitretinoin—peripheral nervous system neoplasm	0.000963	0.00167	CcSEcCtD
Amiloride—Muscle spasms—Cisplatin—peripheral nervous system neoplasm	0.000959	0.00166	CcSEcCtD
Amiloride—SLC9A1—Disease—GNS—peripheral nervous system neoplasm	0.000948	0.00403	CbGpPWpGaD
Amiloride—Shock—Alitretinoin—peripheral nervous system neoplasm	0.00094	0.00163	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Dactinomycin—peripheral nervous system neoplasm	0.000939	0.00163	CcSEcCtD
Amiloride—Tremor—Cisplatin—peripheral nervous system neoplasm	0.000935	0.00162	CcSEcCtD
Amiloride—Alopecia—Etoposide—peripheral nervous system neoplasm	0.000928	0.00161	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—MYC—peripheral nervous system neoplasm	0.000923	0.00392	CbGpPWpGaD
Amiloride—SLC9A1—G Protein Signaling Pathways—HRAS—peripheral nervous system neoplasm	0.000912	0.00388	CbGpPWpGaD
Amiloride—Asthenia—Topotecan—peripheral nervous system neoplasm	0.000912	0.00158	CcSEcCtD
Amiloride—Anorexia—Alitretinoin—peripheral nervous system neoplasm	0.000911	0.00158	CcSEcCtD
Amiloride—Asthenia—Tretinoin—peripheral nervous system neoplasm	0.000905	0.00157	CcSEcCtD
Amiloride—Asthenia—Isotretinoin—peripheral nervous system neoplasm	0.000905	0.00157	CcSEcCtD
Amiloride—Hepatic function abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000901	0.00156	CcSEcCtD
Amiloride—Pruritus—Topotecan—peripheral nervous system neoplasm	0.000899	0.00156	CcSEcCtD
Amiloride—Decreased appetite—Dactinomycin—peripheral nervous system neoplasm	0.000896	0.00155	CcSEcCtD
Amiloride—Asthenia—Melphalan—peripheral nervous system neoplasm	0.000893	0.00155	CcSEcCtD
Amiloride—Pruritus—Isotretinoin—peripheral nervous system neoplasm	0.000892	0.00154	CcSEcCtD
Amiloride—Pruritus—Tretinoin—peripheral nervous system neoplasm	0.000892	0.00154	CcSEcCtD
Amiloride—Fatigue—Dactinomycin—peripheral nervous system neoplasm	0.000888	0.00154	CcSEcCtD
Amiloride—Back pain—Etoposide—peripheral nervous system neoplasm	0.000884	0.00153	CcSEcCtD
Amiloride—Pain—Dactinomycin—peripheral nervous system neoplasm	0.000881	0.00153	CcSEcCtD
Amiloride—Pruritus—Melphalan—peripheral nervous system neoplasm	0.00088	0.00152	CcSEcCtD
Amiloride—Muscle spasms—Etoposide—peripheral nervous system neoplasm	0.000879	0.00152	CcSEcCtD
Amiloride—Anorexia—Vincristine—peripheral nervous system neoplasm	0.000878	0.00152	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Alitretinoin—peripheral nervous system neoplasm	0.00087	0.00151	CcSEcCtD
Amiloride—Diarrhoea—Topotecan—peripheral nervous system neoplasm	0.00087	0.00151	CcSEcCtD
Amiloride—Insomnia—Alitretinoin—peripheral nervous system neoplasm	0.000864	0.0015	CcSEcCtD
Amiloride—Diarrhoea—Isotretinoin—peripheral nervous system neoplasm	0.000863	0.00149	CcSEcCtD
Amiloride—Diarrhoea—Tretinoin—peripheral nervous system neoplasm	0.000863	0.00149	CcSEcCtD
Amiloride—Paraesthesia—Alitretinoin—peripheral nervous system neoplasm	0.000858	0.00149	CcSEcCtD
Amiloride—PLAU—Hemostasis—IFNB1—peripheral nervous system neoplasm	0.000857	0.00364	CbGpPWpGaD
Amiloride—SLC9A1—Regulation of Actin Cytoskeleton—NRAS—peripheral nervous system neoplasm	0.000855	0.00363	CbGpPWpGaD
Amiloride—Hyponatraemia—Epirubicin—peripheral nervous system neoplasm	0.000854	0.00148	CcSEcCtD
Amiloride—Dyspnoea—Alitretinoin—peripheral nervous system neoplasm	0.000852	0.00148	CcSEcCtD
Amiloride—Diarrhoea—Melphalan—peripheral nervous system neoplasm	0.000851	0.00147	CcSEcCtD
Amiloride—Pain in extremity—Epirubicin—peripheral nervous system neoplasm	0.000851	0.00147	CcSEcCtD
Amiloride—Gastrointestinal haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000851	0.00147	CcSEcCtD
Amiloride—Somnolence—Alitretinoin—peripheral nervous system neoplasm	0.000849	0.00147	CcSEcCtD
Amiloride—Feeling abnormal—Dactinomycin—peripheral nervous system neoplasm	0.000849	0.00147	CcSEcCtD
Amiloride—Gastrointestinal pain—Dactinomycin—peripheral nervous system neoplasm	0.000843	0.00146	CcSEcCtD
Amiloride—Dyspepsia—Alitretinoin—peripheral nervous system neoplasm	0.000841	0.00146	CcSEcCtD
Amiloride—Dizziness—Topotecan—peripheral nervous system neoplasm	0.00084	0.00146	CcSEcCtD
Amiloride—Musculoskeletal discomfort—Vincristine—peripheral nervous system neoplasm	0.000839	0.00145	CcSEcCtD
Amiloride—Dizziness—Isotretinoin—peripheral nervous system neoplasm	0.000834	0.00144	CcSEcCtD
Amiloride—Dizziness—Tretinoin—peripheral nervous system neoplasm	0.000834	0.00144	CcSEcCtD
Amiloride—Insomnia—Vincristine—peripheral nervous system neoplasm	0.000833	0.00144	CcSEcCtD
Amiloride—Decreased appetite—Alitretinoin—peripheral nervous system neoplasm	0.000831	0.00144	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000828	0.00352	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—HRAS—peripheral nervous system neoplasm	0.000828	0.00352	CbGpPWpGaD
Amiloride—Paraesthesia—Vincristine—peripheral nervous system neoplasm	0.000827	0.00143	CcSEcCtD
Amiloride—Gastrointestinal disorder—Alitretinoin—peripheral nervous system neoplasm	0.000825	0.00143	CcSEcCtD
Amiloride—Fatigue—Alitretinoin—peripheral nervous system neoplasm	0.000824	0.00143	CcSEcCtD
Amiloride—Vertigo—Etoposide—peripheral nervous system neoplasm	0.000821	0.00142	CcSEcCtD
Amiloride—Constipation—Alitretinoin—peripheral nervous system neoplasm	0.000817	0.00141	CcSEcCtD
Amiloride—Pain—Alitretinoin—peripheral nervous system neoplasm	0.000817	0.00141	CcSEcCtD
Amiloride—Abdominal pain—Dactinomycin—peripheral nervous system neoplasm	0.000815	0.00141	CcSEcCtD
Amiloride—Vomiting—Topotecan—peripheral nervous system neoplasm	0.000808	0.0014	CcSEcCtD
Amiloride—Vomiting—Tretinoin—peripheral nervous system neoplasm	0.000802	0.00139	CcSEcCtD
Amiloride—Vomiting—Isotretinoin—peripheral nervous system neoplasm	0.000802	0.00139	CcSEcCtD
Amiloride—Rash—Topotecan—peripheral nervous system neoplasm	0.000801	0.00139	CcSEcCtD
Amiloride—Dermatitis—Topotecan—peripheral nervous system neoplasm	0.000801	0.00139	CcSEcCtD
Amiloride—Decreased appetite—Vincristine—peripheral nervous system neoplasm	0.0008	0.00139	CcSEcCtD
Amiloride—PLAU—Wnt Signaling Pathway and Pluripotency—TP53—peripheral nervous system neoplasm	0.000799	0.0034	CbGpPWpGaD
Amiloride—Cough—Etoposide—peripheral nervous system neoplasm	0.000797	0.00138	CcSEcCtD
Amiloride—Headache—Topotecan—peripheral nervous system neoplasm	0.000796	0.00138	CcSEcCtD
Amiloride—Rash—Isotretinoin—peripheral nervous system neoplasm	0.000795	0.00138	CcSEcCtD
Amiloride—Rash—Tretinoin—peripheral nervous system neoplasm	0.000795	0.00138	CcSEcCtD
Amiloride—Gastrointestinal disorder—Vincristine—peripheral nervous system neoplasm	0.000795	0.00138	CcSEcCtD
Amiloride—SLC9A1—Metabolism—GNS—peripheral nervous system neoplasm	0.000794	0.00338	CbGpPWpGaD
Amiloride—Dermatitis—Isotretinoin—peripheral nervous system neoplasm	0.000794	0.00138	CcSEcCtD
Amiloride—Dermatitis—Tretinoin—peripheral nervous system neoplasm	0.000794	0.00138	CcSEcCtD
Amiloride—PLAU—Hemostasis—KNG1—peripheral nervous system neoplasm	0.000794	0.00337	CbGpPWpGaD
Amiloride—Fatigue—Vincristine—peripheral nervous system neoplasm	0.000794	0.00137	CcSEcCtD
Amiloride—Vomiting—Melphalan—peripheral nervous system neoplasm	0.000791	0.00137	CcSEcCtD
Amiloride—Hyponatraemia—Doxorubicin—peripheral nervous system neoplasm	0.00079	0.00137	CcSEcCtD
Amiloride—Headache—Tretinoin—peripheral nervous system neoplasm	0.00079	0.00137	CcSEcCtD
Amiloride—Headache—Isotretinoin—peripheral nervous system neoplasm	0.00079	0.00137	CcSEcCtD
Amiloride—Feeling abnormal—Alitretinoin—peripheral nervous system neoplasm	0.000787	0.00136	CcSEcCtD
Amiloride—Constipation—Vincristine—peripheral nervous system neoplasm	0.000787	0.00136	CcSEcCtD
Amiloride—Pain—Vincristine—peripheral nervous system neoplasm	0.000787	0.00136	CcSEcCtD
Amiloride—Pain in extremity—Doxorubicin—peripheral nervous system neoplasm	0.000787	0.00136	CcSEcCtD
Amiloride—Gastrointestinal haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000787	0.00136	CcSEcCtD
Amiloride—Rash—Melphalan—peripheral nervous system neoplasm	0.000785	0.00136	CcSEcCtD
Amiloride—Dermatitis—Melphalan—peripheral nervous system neoplasm	0.000784	0.00136	CcSEcCtD
Amiloride—Gastrointestinal pain—Alitretinoin—peripheral nervous system neoplasm	0.000781	0.00135	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—TP53—peripheral nervous system neoplasm	0.000781	0.00332	CbGpPWpGaD
Amiloride—Chest pain—Etoposide—peripheral nervous system neoplasm	0.000778	0.00135	CcSEcCtD
Amiloride—Orthostatic hypotension—Epirubicin—peripheral nervous system neoplasm	0.000777	0.00135	CcSEcCtD
Amiloride—Anorexia—Cisplatin—peripheral nervous system neoplasm	0.000776	0.00134	CcSEcCtD
Amiloride—SLC9A1—Metabolism—NME1—peripheral nervous system neoplasm	0.000761	0.00324	CbGpPWpGaD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—TP53—peripheral nervous system neoplasm	0.000758	0.00322	CbGpPWpGaD
Amiloride—Abdominal pain—Alitretinoin—peripheral nervous system neoplasm	0.000755	0.00131	CcSEcCtD
Amiloride—Nausea—Topotecan—peripheral nervous system neoplasm	0.000755	0.00131	CcSEcCtD
Amiloride—Gastrointestinal pain—Vincristine—peripheral nervous system neoplasm	0.000753	0.0013	CcSEcCtD
Amiloride—Confusional state—Etoposide—peripheral nervous system neoplasm	0.000752	0.0013	CcSEcCtD
Amiloride—Muscular weakness—Epirubicin—peripheral nervous system neoplasm	0.00075	0.0013	CcSEcCtD
Amiloride—Nausea—Isotretinoin—peripheral nervous system neoplasm	0.000749	0.0013	CcSEcCtD
Amiloride—Nausea—Tretinoin—peripheral nervous system neoplasm	0.000749	0.0013	CcSEcCtD
Amiloride—PLAU—Senescence and Autophagy in Cancer—HRAS—peripheral nervous system neoplasm	0.000747	0.00317	CbGpPWpGaD
Amiloride—SLC22A4—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000746	0.00317	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Cisplatin—peripheral nervous system neoplasm	0.000742	0.00128	CcSEcCtD
Amiloride—Abdominal distension—Epirubicin—peripheral nervous system neoplasm	0.00074	0.00128	CcSEcCtD
Amiloride—Asthenia—Dactinomycin—peripheral nervous system neoplasm	0.000739	0.00128	CcSEcCtD
Amiloride—Nausea—Melphalan—peripheral nervous system neoplasm	0.000739	0.00128	CcSEcCtD
Amiloride—SLC9A1—Metabolism—COX2—peripheral nervous system neoplasm	0.000733	0.00312	CbGpPWpGaD
Amiloride—SLC9A1—ErbB1 downstream signaling—AKT1—peripheral nervous system neoplasm	0.000731	0.00311	CbGpPWpGaD
Amiloride—Paraesthesia—Cisplatin—peripheral nervous system neoplasm	0.000731	0.00127	CcSEcCtD
Amiloride—Abdominal pain—Vincristine—peripheral nervous system neoplasm	0.000728	0.00126	CcSEcCtD
Amiloride—Dyspnoea—Cisplatin—peripheral nervous system neoplasm	0.000726	0.00126	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—HRAS—peripheral nervous system neoplasm	0.000725	0.00308	CbGpPWpGaD
Amiloride—Orthostatic hypotension—Doxorubicin—peripheral nervous system neoplasm	0.000719	0.00124	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000716	0.00304	CbGpPWpGaD
Amiloride—Angina pectoris—Epirubicin—peripheral nervous system neoplasm	0.000716	0.00124	CcSEcCtD
Amiloride—Anorexia—Etoposide—peripheral nervous system neoplasm	0.000711	0.00123	CcSEcCtD
Amiloride—Decreased appetite—Cisplatin—peripheral nervous system neoplasm	0.000708	0.00123	CcSEcCtD
Amiloride—Diarrhoea—Dactinomycin—peripheral nervous system neoplasm	0.000705	0.00122	CcSEcCtD
Amiloride—Gastrointestinal disorder—Cisplatin—peripheral nervous system neoplasm	0.000703	0.00122	CcSEcCtD
Amiloride—Pain—Cisplatin—peripheral nervous system neoplasm	0.000696	0.00121	CcSEcCtD
Amiloride—PLAU—Hemostasis—GNAS—peripheral nervous system neoplasm	0.000694	0.00295	CbGpPWpGaD
Amiloride—Muscular weakness—Doxorubicin—peripheral nervous system neoplasm	0.000694	0.0012	CcSEcCtD
Amiloride—Neutropenia—Epirubicin—peripheral nervous system neoplasm	0.000687	0.00119	CcSEcCtD
Amiloride—Dysuria—Epirubicin—peripheral nervous system neoplasm	0.000687	0.00119	CcSEcCtD
Amiloride—Asthenia—Alitretinoin—peripheral nervous system neoplasm	0.000685	0.00119	CcSEcCtD
Amiloride—Abdominal distension—Doxorubicin—peripheral nervous system neoplasm	0.000685	0.00119	CcSEcCtD
Amiloride—Pollakiuria—Epirubicin—peripheral nervous system neoplasm	0.000679	0.00118	CcSEcCtD
Amiloride—Pruritus—Alitretinoin—peripheral nervous system neoplasm	0.000676	0.00117	CcSEcCtD
Amiloride—Feeling abnormal—Cisplatin—peripheral nervous system neoplasm	0.000671	0.00116	CcSEcCtD
Amiloride—Paraesthesia—Etoposide—peripheral nervous system neoplasm	0.00067	0.00116	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000666	0.00283	CbGpPWpGaD
Amiloride—Dyspnoea—Etoposide—peripheral nervous system neoplasm	0.000665	0.00115	CcSEcCtD
Amiloride—SLC9A1—Disease—PPP3R1—peripheral nervous system neoplasm	0.000663	0.00282	CbGpPWpGaD
Amiloride—Somnolence—Etoposide—peripheral nervous system neoplasm	0.000663	0.00115	CcSEcCtD
Amiloride—Angina pectoris—Doxorubicin—peripheral nervous system neoplasm	0.000663	0.00115	CcSEcCtD
Amiloride—PLAU—Hemostasis—HGF—peripheral nervous system neoplasm	0.000661	0.00281	CbGpPWpGaD
Amiloride—Asthenia—Vincristine—peripheral nervous system neoplasm	0.000661	0.00114	CcSEcCtD
Amiloride—Vomiting—Dactinomycin—peripheral nervous system neoplasm	0.000655	0.00113	CcSEcCtD
Amiloride—SLC9A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000654	0.00278	CbGpPWpGaD
Amiloride—Diarrhoea—Alitretinoin—peripheral nervous system neoplasm	0.000654	0.00113	CcSEcCtD
Amiloride—Rash—Dactinomycin—peripheral nervous system neoplasm	0.00065	0.00113	CcSEcCtD
Amiloride—Decreased appetite—Etoposide—peripheral nervous system neoplasm	0.000648	0.00112	CcSEcCtD
Amiloride—Gastrointestinal disorder—Etoposide—peripheral nervous system neoplasm	0.000644	0.00112	CcSEcCtD
Amiloride—Fatigue—Etoposide—peripheral nervous system neoplasm	0.000643	0.00111	CcSEcCtD
Amiloride—PLAU—DNA Damage Response (only ATM dependent)—AKT1—peripheral nervous system neoplasm	0.00064	0.00272	CbGpPWpGaD
Amiloride—Jaundice—Epirubicin—peripheral nervous system neoplasm	0.000639	0.00111	CcSEcCtD
Amiloride—Constipation—Etoposide—peripheral nervous system neoplasm	0.000638	0.0011	CcSEcCtD
Amiloride—Pain—Etoposide—peripheral nervous system neoplasm	0.000638	0.0011	CcSEcCtD
Amiloride—Neutropenia—Doxorubicin—peripheral nervous system neoplasm	0.000636	0.0011	CcSEcCtD
Amiloride—Dysuria—Doxorubicin—peripheral nervous system neoplasm	0.000636	0.0011	CcSEcCtD
Amiloride—Dizziness—Alitretinoin—peripheral nervous system neoplasm	0.000632	0.00109	CcSEcCtD
Amiloride—Diarrhoea—Vincristine—peripheral nervous system neoplasm	0.00063	0.00109	CcSEcCtD
Amiloride—Pollakiuria—Doxorubicin—peripheral nervous system neoplasm	0.000628	0.00109	CcSEcCtD
Amiloride—Feeling abnormal—Etoposide—peripheral nervous system neoplasm	0.000615	0.00106	CcSEcCtD
Amiloride—Nausea—Dactinomycin—peripheral nervous system neoplasm	0.000612	0.00106	CcSEcCtD
Amiloride—Gastrointestinal pain—Etoposide—peripheral nervous system neoplasm	0.00061	0.00106	CcSEcCtD
Amiloride—Dizziness—Vincristine—peripheral nervous system neoplasm	0.000609	0.00105	CcSEcCtD
Amiloride—Vomiting—Alitretinoin—peripheral nervous system neoplasm	0.000607	0.00105	CcSEcCtD
Amiloride—Rash—Alitretinoin—peripheral nervous system neoplasm	0.000602	0.00104	CcSEcCtD
Amiloride—Dermatitis—Alitretinoin—peripheral nervous system neoplasm	0.000602	0.00104	CcSEcCtD
Amiloride—Bradycardia—Epirubicin—peripheral nervous system neoplasm	0.000599	0.00104	CcSEcCtD
Amiloride—Headache—Alitretinoin—peripheral nervous system neoplasm	0.000599	0.00104	CcSEcCtD
Amiloride—Haemoglobin—Epirubicin—peripheral nervous system neoplasm	0.000591	0.00102	CcSEcCtD
Amiloride—Jaundice—Doxorubicin—peripheral nervous system neoplasm	0.000591	0.00102	CcSEcCtD
Amiloride—Abdominal pain—Etoposide—peripheral nervous system neoplasm	0.00059	0.00102	CcSEcCtD
Amiloride—Haemorrhage—Epirubicin—peripheral nervous system neoplasm	0.000588	0.00102	CcSEcCtD
Amiloride—Vomiting—Vincristine—peripheral nervous system neoplasm	0.000585	0.00101	CcSEcCtD
Amiloride—Asthenia—Cisplatin—peripheral nervous system neoplasm	0.000584	0.00101	CcSEcCtD
Amiloride—Rash—Vincristine—peripheral nervous system neoplasm	0.00058	0.00101	CcSEcCtD
Amiloride—Dermatitis—Vincristine—peripheral nervous system neoplasm	0.00058	0.001	CcSEcCtD
Amiloride—Headache—Vincristine—peripheral nervous system neoplasm	0.000577	0.000999	CcSEcCtD
Amiloride—SLC9A1—Disease—ENO2—peripheral nervous system neoplasm	0.000575	0.00244	CbGpPWpGaD
Amiloride—Nausea—Alitretinoin—peripheral nervous system neoplasm	0.000568	0.000983	CcSEcCtD
Amiloride—Visual impairment—Epirubicin—peripheral nervous system neoplasm	0.000567	0.000982	CcSEcCtD
Amiloride—Diarrhoea—Cisplatin—peripheral nervous system neoplasm	0.000557	0.000965	CcSEcCtD
Amiloride—Bradycardia—Doxorubicin—peripheral nervous system neoplasm	0.000554	0.00096	CcSEcCtD
Amiloride—Tinnitus—Epirubicin—peripheral nervous system neoplasm	0.000549	0.00095	CcSEcCtD
Amiloride—Haemoglobin—Doxorubicin—peripheral nervous system neoplasm	0.000547	0.000948	CcSEcCtD
Amiloride—Nausea—Vincristine—peripheral nervous system neoplasm	0.000547	0.000947	CcSEcCtD
Amiloride—Haemorrhage—Doxorubicin—peripheral nervous system neoplasm	0.000544	0.000943	CcSEcCtD
Amiloride—Asthenia—Etoposide—peripheral nervous system neoplasm	0.000535	0.000927	CcSEcCtD
Amiloride—Pruritus—Etoposide—peripheral nervous system neoplasm	0.000528	0.000914	CcSEcCtD
Amiloride—Visual impairment—Doxorubicin—peripheral nervous system neoplasm	0.000525	0.000909	CcSEcCtD
Amiloride—Alopecia—Epirubicin—peripheral nervous system neoplasm	0.00052	0.0009	CcSEcCtD
Amiloride—Vomiting—Cisplatin—peripheral nervous system neoplasm	0.000518	0.000896	CcSEcCtD
Amiloride—Rash—Cisplatin—peripheral nervous system neoplasm	0.000513	0.000889	CcSEcCtD
Amiloride—Dermatitis—Cisplatin—peripheral nervous system neoplasm	0.000513	0.000888	CcSEcCtD
Amiloride—Diarrhoea—Etoposide—peripheral nervous system neoplasm	0.00051	0.000884	CcSEcCtD
Amiloride—Tinnitus—Doxorubicin—peripheral nervous system neoplasm	0.000508	0.000879	CcSEcCtD
Amiloride—Flatulence—Epirubicin—peripheral nervous system neoplasm	0.000505	0.000874	CcSEcCtD
Amiloride—Tension—Epirubicin—peripheral nervous system neoplasm	0.000503	0.00087	CcSEcCtD
Amiloride—Nervousness—Epirubicin—peripheral nervous system neoplasm	0.000498	0.000862	CcSEcCtD
Amiloride—Back pain—Epirubicin—peripheral nervous system neoplasm	0.000495	0.000858	CcSEcCtD
Amiloride—Dizziness—Etoposide—peripheral nervous system neoplasm	0.000493	0.000854	CcSEcCtD
Amiloride—Muscle spasms—Epirubicin—peripheral nervous system neoplasm	0.000492	0.000853	CcSEcCtD
Amiloride—Nausea—Cisplatin—peripheral nervous system neoplasm	0.000484	0.000837	CcSEcCtD
Amiloride—PLAU—Hemostasis—PTPN11—peripheral nervous system neoplasm	0.000482	0.00205	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ENO2—peripheral nervous system neoplasm	0.000481	0.00205	CbGpPWpGaD
Amiloride—Alopecia—Doxorubicin—peripheral nervous system neoplasm	0.000481	0.000833	CcSEcCtD
Amiloride—Vomiting—Etoposide—peripheral nervous system neoplasm	0.000474	0.000821	CcSEcCtD
Amiloride—Rash—Etoposide—peripheral nervous system neoplasm	0.00047	0.000814	CcSEcCtD
Amiloride—Dermatitis—Etoposide—peripheral nervous system neoplasm	0.00047	0.000814	CcSEcCtD
Amiloride—Headache—Etoposide—peripheral nervous system neoplasm	0.000467	0.000809	CcSEcCtD
Amiloride—Flatulence—Doxorubicin—peripheral nervous system neoplasm	0.000467	0.000809	CcSEcCtD
Amiloride—Tension—Doxorubicin—peripheral nervous system neoplasm	0.000465	0.000805	CcSEcCtD
Amiloride—SLC9A1—Disease—SLC2A1—peripheral nervous system neoplasm	0.000463	0.00197	CbGpPWpGaD
Amiloride—Nervousness—Doxorubicin—peripheral nervous system neoplasm	0.00046	0.000797	CcSEcCtD
Amiloride—Vertigo—Epirubicin—peripheral nervous system neoplasm	0.00046	0.000797	CcSEcCtD
Amiloride—Back pain—Doxorubicin—peripheral nervous system neoplasm	0.000458	0.000794	CcSEcCtD
Amiloride—SLC22A2—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000456	0.00194	CbGpPWpGaD
Amiloride—Muscle spasms—Doxorubicin—peripheral nervous system neoplasm	0.000456	0.000789	CcSEcCtD
Amiloride—Palpitations—Epirubicin—peripheral nervous system neoplasm	0.000453	0.000784	CcSEcCtD
Amiloride—Cough—Epirubicin—peripheral nervous system neoplasm	0.000447	0.000774	CcSEcCtD
Amiloride—Nausea—Etoposide—peripheral nervous system neoplasm	0.000443	0.000767	CcSEcCtD
Amiloride—Chest pain—Epirubicin—peripheral nervous system neoplasm	0.000436	0.000755	CcSEcCtD
Amiloride—Arthralgia—Epirubicin—peripheral nervous system neoplasm	0.000436	0.000755	CcSEcCtD
Amiloride—Vertigo—Doxorubicin—peripheral nervous system neoplasm	0.000426	0.000737	CcSEcCtD
Amiloride—SLC22A1—Transmission across Chemical Synapses—BCHE—peripheral nervous system neoplasm	0.000425	0.00181	CbGpPWpGaD
Amiloride—Confusional state—Epirubicin—peripheral nervous system neoplasm	0.000422	0.00073	CcSEcCtD
Amiloride—Palpitations—Doxorubicin—peripheral nervous system neoplasm	0.000419	0.000725	CcSEcCtD
Amiloride—Cough—Doxorubicin—peripheral nervous system neoplasm	0.000414	0.000716	CcSEcCtD
Amiloride—Shock—Epirubicin—peripheral nervous system neoplasm	0.000411	0.000712	CcSEcCtD
Amiloride—SLC9A1—Metabolism—BCHE—peripheral nervous system neoplasm	0.000407	0.00173	CbGpPWpGaD
Amiloride—Arthralgia—Doxorubicin—peripheral nervous system neoplasm	0.000404	0.000699	CcSEcCtD
Amiloride—Chest pain—Doxorubicin—peripheral nervous system neoplasm	0.000404	0.000699	CcSEcCtD
Amiloride—Anorexia—Epirubicin—peripheral nervous system neoplasm	0.000398	0.00069	CcSEcCtD
Amiloride—Confusional state—Doxorubicin—peripheral nervous system neoplasm	0.00039	0.000675	CcSEcCtD
Amiloride—SLC9A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	0.000388	0.00165	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—TH—peripheral nervous system neoplasm	0.000382	0.00162	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Epirubicin—peripheral nervous system neoplasm	0.000381	0.00066	CcSEcCtD
Amiloride—Shock—Doxorubicin—peripheral nervous system neoplasm	0.000381	0.000659	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000379	0.00161	CbGpPWpGaD
Amiloride—Insomnia—Epirubicin—peripheral nervous system neoplasm	0.000378	0.000655	CcSEcCtD
Amiloride—Paraesthesia—Epirubicin—peripheral nervous system neoplasm	0.000375	0.00065	CcSEcCtD
Amiloride—Dyspnoea—Epirubicin—peripheral nervous system neoplasm	0.000373	0.000645	CcSEcCtD
Amiloride—Somnolence—Epirubicin—peripheral nervous system neoplasm	0.000372	0.000644	CcSEcCtD
Amiloride—Anorexia—Doxorubicin—peripheral nervous system neoplasm	0.000369	0.000639	CcSEcCtD
Amiloride—Dyspepsia—Epirubicin—peripheral nervous system neoplasm	0.000368	0.000637	CcSEcCtD
Amiloride—Decreased appetite—Epirubicin—peripheral nervous system neoplasm	0.000363	0.000629	CcSEcCtD
Amiloride—Gastrointestinal disorder—Epirubicin—peripheral nervous system neoplasm	0.000361	0.000625	CcSEcCtD
Amiloride—Fatigue—Epirubicin—peripheral nervous system neoplasm	0.00036	0.000624	CcSEcCtD
Amiloride—Pain—Epirubicin—peripheral nervous system neoplasm	0.000357	0.000619	CcSEcCtD
Amiloride—Constipation—Epirubicin—peripheral nervous system neoplasm	0.000357	0.000619	CcSEcCtD
Amiloride—SLC22A2—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000353	0.0015	CbGpPWpGaD
Amiloride—Musculoskeletal discomfort—Doxorubicin—peripheral nervous system neoplasm	0.000352	0.00061	CcSEcCtD
Amiloride—SLC22A2—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000352	0.0015	CbGpPWpGaD
Amiloride—Insomnia—Doxorubicin—peripheral nervous system neoplasm	0.00035	0.000606	CcSEcCtD
Amiloride—SLC22A2—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000349	0.00149	CbGpPWpGaD
Amiloride—Paraesthesia—Doxorubicin—peripheral nervous system neoplasm	0.000347	0.000602	CcSEcCtD
Amiloride—Dyspnoea—Doxorubicin—peripheral nervous system neoplasm	0.000345	0.000597	CcSEcCtD
Amiloride—Feeling abnormal—Epirubicin—peripheral nervous system neoplasm	0.000344	0.000597	CcSEcCtD
Amiloride—Somnolence—Doxorubicin—peripheral nervous system neoplasm	0.000344	0.000596	CcSEcCtD
Amiloride—Gastrointestinal pain—Epirubicin—peripheral nervous system neoplasm	0.000342	0.000592	CcSEcCtD
Amiloride—Dyspepsia—Doxorubicin—peripheral nervous system neoplasm	0.00034	0.00059	CcSEcCtD
Amiloride—SLC22A2—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000339	0.00144	CbGpPWpGaD
Amiloride—Decreased appetite—Doxorubicin—peripheral nervous system neoplasm	0.000336	0.000582	CcSEcCtD
Amiloride—Gastrointestinal disorder—Doxorubicin—peripheral nervous system neoplasm	0.000334	0.000578	CcSEcCtD
Amiloride—Fatigue—Doxorubicin—peripheral nervous system neoplasm	0.000333	0.000578	CcSEcCtD
Amiloride—Pain—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.000573	CcSEcCtD
Amiloride—Constipation—Doxorubicin—peripheral nervous system neoplasm	0.000331	0.000573	CcSEcCtD
Amiloride—Abdominal pain—Epirubicin—peripheral nervous system neoplasm	0.00033	0.000572	CcSEcCtD
Amiloride—SLC22A1—SLC-mediated transmembrane transport—SLC2A1—peripheral nervous system neoplasm	0.000329	0.0014	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—PPIP5K2—peripheral nervous system neoplasm	0.000328	0.00139	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—BCHE—peripheral nervous system neoplasm	0.000326	0.00138	CbGpPWpGaD
Amiloride—Feeling abnormal—Doxorubicin—peripheral nervous system neoplasm	0.000319	0.000552	CcSEcCtD
Amiloride—Gastrointestinal pain—Doxorubicin—peripheral nervous system neoplasm	0.000316	0.000548	CcSEcCtD
Amiloride—SLC22A1—Transmembrane transport of small molecules—COX2—peripheral nervous system neoplasm	0.000316	0.00134	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—GNAS—peripheral nervous system neoplasm	0.000312	0.00133	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—ABCB1—peripheral nervous system neoplasm	0.000306	0.0013	CbGpPWpGaD
Amiloride—Abdominal pain—Doxorubicin—peripheral nervous system neoplasm	0.000306	0.00053	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000305	0.0013	CbGpPWpGaD
Amiloride—Asthenia—Epirubicin—peripheral nervous system neoplasm	0.0003	0.000519	CcSEcCtD
Amiloride—SLC22A4—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000299	0.00127	CbGpPWpGaD
Amiloride—Pruritus—Epirubicin—peripheral nervous system neoplasm	0.000296	0.000512	CcSEcCtD
Amiloride—PLAU—Hemostasis—NRAS—peripheral nervous system neoplasm	0.00029	0.00123	CbGpPWpGaD
Amiloride—Diarrhoea—Epirubicin—peripheral nervous system neoplasm	0.000286	0.000495	CcSEcCtD
Amiloride—Asthenia—Doxorubicin—peripheral nervous system neoplasm	0.000278	0.000481	CcSEcCtD
Amiloride—Dizziness—Epirubicin—peripheral nervous system neoplasm	0.000276	0.000479	CcSEcCtD
Amiloride—Pruritus—Doxorubicin—peripheral nervous system neoplasm	0.000274	0.000474	CcSEcCtD
Amiloride—Vomiting—Epirubicin—peripheral nervous system neoplasm	0.000266	0.00046	CcSEcCtD
Amiloride—Diarrhoea—Doxorubicin—peripheral nervous system neoplasm	0.000265	0.000458	CcSEcCtD
Amiloride—Rash—Epirubicin—peripheral nervous system neoplasm	0.000264	0.000456	CcSEcCtD
Amiloride—Dermatitis—Epirubicin—peripheral nervous system neoplasm	0.000263	0.000456	CcSEcCtD
Amiloride—Headache—Epirubicin—peripheral nervous system neoplasm	0.000262	0.000454	CcSEcCtD
Amiloride—SLC9A1—Disease—PTPN11—peripheral nervous system neoplasm	0.000259	0.0011	CbGpPWpGaD
Amiloride—Dizziness—Doxorubicin—peripheral nervous system neoplasm	0.000256	0.000443	CcSEcCtD
Amiloride—Nausea—Epirubicin—peripheral nervous system neoplasm	0.000248	0.00043	CcSEcCtD
Amiloride—Vomiting—Doxorubicin—peripheral nervous system neoplasm	0.000246	0.000426	CcSEcCtD
Amiloride—Rash—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000422	CcSEcCtD
Amiloride—Dermatitis—Doxorubicin—peripheral nervous system neoplasm	0.000244	0.000422	CcSEcCtD
Amiloride—Headache—Doxorubicin—peripheral nervous system neoplasm	0.000242	0.00042	CcSEcCtD
Amiloride—SLC22A2—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000238	0.00101	CbGpPWpGaD
Amiloride—Nausea—Doxorubicin—peripheral nervous system neoplasm	0.00023	0.000398	CcSEcCtD
Amiloride—PLAU—Hemostasis—TP53—peripheral nervous system neoplasm	0.000222	0.000943	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—HSD17B12—peripheral nervous system neoplasm	0.000222	0.000942	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—HRAS—peripheral nervous system neoplasm	0.000212	0.000902	CbGpPWpGaD
Amiloride—SLC9A1—Disease—ERBB2—peripheral nervous system neoplasm	0.000205	0.00087	CbGpPWpGaD
Amiloride—PLAU—Hemostasis—AKT1—peripheral nervous system neoplasm	0.000187	0.000796	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000179	0.000762	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GNS—peripheral nervous system neoplasm	0.000172	0.000731	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—SLC2A1—peripheral nervous system neoplasm	0.000167	0.00071	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—NME1—peripheral nervous system neoplasm	0.000165	0.0007	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GNS—peripheral nervous system neoplasm	0.00016	0.000681	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—COX2—peripheral nervous system neoplasm	0.000159	0.000674	CbGpPWpGaD
Amiloride—SLC9A1—Disease—NRAS—peripheral nervous system neoplasm	0.000156	0.000662	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—NME1—peripheral nervous system neoplasm	0.000154	0.000653	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—COX2—peripheral nervous system neoplasm	0.000148	0.000628	CbGpPWpGaD
Amiloride—SLC9A1—Disease—MYC—peripheral nervous system neoplasm	0.000145	0.000616	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000144	0.000613	CbGpPWpGaD
Amiloride—SLC22A2—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000142	0.000601	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—GNAS—peripheral nervous system neoplasm	0.000134	0.000571	CbGpPWpGaD
Amiloride—SLC22A1—Transmembrane transport of small molecules—ABCB1—peripheral nervous system neoplasm	0.000132	0.000561	CbGpPWpGaD
Amiloride—SLC9A1—Disease—HRAS—peripheral nervous system neoplasm	0.000114	0.000484	CbGpPWpGaD
Amiloride—SLC22A2—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	0.000107	0.000455	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ENO2—peripheral nervous system neoplasm	0.000104	0.000443	CbGpPWpGaD
Amiloride—SLC9A1—Disease—AKT1—peripheral nervous system neoplasm	0.000101	0.000427	CbGpPWpGaD
Amiloride—SLC22A1—Transmission across Chemical Synapses—HRAS—peripheral nervous system neoplasm	9.97e-05	0.000424	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ENO2—peripheral nervous system neoplasm	9.71e-05	0.000413	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—BCHE—peripheral nervous system neoplasm	8.8e-05	0.000374	CbGpPWpGaD
Amiloride—SLC9A1—Metabolism—AKT1—peripheral nervous system neoplasm	8.42e-05	0.000358	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—SLC2A1—peripheral nervous system neoplasm	8.4e-05	0.000357	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—TH—peripheral nervous system neoplasm	8.27e-05	0.000352	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—BCHE—peripheral nervous system neoplasm	8.2e-05	0.000349	CbGpPWpGaD
Amiloride—SLC22A2—Neuronal System—HRAS—peripheral nervous system neoplasm	8.2e-05	0.000348	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—SLC2A1—peripheral nervous system neoplasm	7.83e-05	0.000333	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—TH—peripheral nervous system neoplasm	7.71e-05	0.000328	CbGpPWpGaD
Amiloride—SLC22A1—Neuronal System—HRAS—peripheral nervous system neoplasm	7.64e-05	0.000325	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—GNAS—peripheral nervous system neoplasm	6.75e-05	0.000287	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—ABCB1—peripheral nervous system neoplasm	6.63e-05	0.000282	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—GNAS—peripheral nervous system neoplasm	6.3e-05	0.000268	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—ABCB1—peripheral nervous system neoplasm	6.18e-05	0.000263	CbGpPWpGaD
Amiloride—SLC22A2—Metabolism—AKT1—peripheral nervous system neoplasm	1.82e-05	7.75e-05	CbGpPWpGaD
Amiloride—SLC22A1—Metabolism—AKT1—peripheral nervous system neoplasm	1.7e-05	7.22e-05	CbGpPWpGaD
